Neuron23 is Drug Discovery in United States that focus on AI)-enabled drug business. Founded in 2018. They cover business area such as operator, precision medicine, genetically define neurological and immunological disease, recent advance, human genetic, the-art, ai)-enable drug discovery and biomarker platform, therapeutic, devastating disease, patient, genetic disorder.
2018
( 6 years old in 2024 )
AI)-enabled Drug
-
681 Gateway Boulevard
3rd Floor
South San Francisco, CA 94080
United States
Private
operatorprecision medicinegenetically define neurological and immunological diseaserecent advancehuman geneticthe-artai)-enable drug discovery and biomarker platformtherapeuticdevastating diseasepatientgenetic disorder
* We use standard office opening hours in near Neuron23's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Neuron23 is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Neuron23 business is focusing on AI)-enabled Drug.
Neuron23 headquarter office and corporate office address is located in 681 Gateway Boulevard 3rd Floor South San Francisco, CA 94080 United States.
Neuron23 was founded in United States.
In 2024, Neuron23 is currently focus on AI)-enabled drug sector.
Above is snippet of Google Trends for "AI)-enabled drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Neuron23, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
